KUALA LUMPUR, June 28 (Bernama) -- CGS-CIMB Securities Sdn Bhd (CGS-CIMB) is positive on Pharmaniaga Bhd (Pharmaniaga) on the expectation of a decent financial year 2023-2024 (FY23-24) earnings growth for the company.
The outlook is underpinned by the ample excess capacity at the company's existing plants and consumer healthcare expansion, the brokerage said in a research note today.
“The ample excess production capacity at Pharmaniaga’s existing plants will allow it to ramp up output in the next three to five years -- in light of rising pharmaceutical demand and new product launches -- with little to no incremental capital expenditure, thus potentially leading to better economies of scale and margins,” it said.
Meanwhile, it noted that Pharmaniaga’s new 10-year logistics and distribution government concession agreement -- to be inked by year-end -- will include a more stringent maximum delivery timeframe of five working days for medicines, compared to the current seven days, with monetary penalties imposed for non-compliance.
“Nonetheless, the company does not foresee any major challenges complying with the new requirements as it currently delivers within four days, on average,” said CGS-CIMB.
As such, the research firm reiterated its 'add' call for Pharmaniaga, but with a lower target price of 73 sen from 79 sen previously.
At 11 am, the company's share price was flat at 60 sen with 117,900 shares traded.
-- BERNAMA
Bernama is the trusted source of reliable real-time comprehensive and accurate news for both the public and media practitioners. Our news is published at www.bernama.com ; BERNAMA TV on: Astro Channel 502, unifi TV Channel 631, MYTV Channel 121 IFLIX; and Bernama Radio broadcasting locally on FM93.9 in Klang Valley, Johor (FM107.5), Kota Kinabalu (FM107.9) and Kuching (FM100.9).
Follow us on social media :
Facebook : @bernamaofficial, @bernamatv, @bernamaradio
Twitter : @bernama.com, @BernamaTV, @bernamaradio
Instagram : @bernamaofficial, @bernamatvofficial, @bernamaradioofficial
TikTok : @bernamaofficial
© 2022 BERNAMA • Disclaimer • Privacy Policy • Security Policy